abrdn Life Sciences Investors Shares of

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.

BIOTECH GROWTH TRUST (THE) PLCBIOG · Asset ManagementLondon, United Kingdom

67% matchPublic

The Biotech Growth Trust PLC, a closed-ended equity investment vehicle, was originally established by Frostrow Capital LLP and is jointly managed by OrbiMed Capital LLC. Formed on May 20, 1997, and legally based in the United Kingdom, this trust allocates its capital to global public equity markets. Its primary objective is to invest in shares of companies operating within the biotechnology sector, spanning the full range of market capitalizations. The construction of its investment portfolio relies on rigorous fundamental analysis, and its performance is benchmarked against the NASDAQ Biotechnology Index. It was previously identified as Finsbury Emerging Biotechnology Trust PLC.

BMO Global Smaller Companies PLC operates as a closed-ended equity investment trust, with F&C Investment Business Ltd responsible for its management. The trust's core objective is to invest in publicly traded small-capitalization companies across various global sectors. Its strategy involves identifying both growth-oriented and value opportunities within the small-cap market. Portfolio construction is guided by rigorous fundamental analysis, examining factors such as the caliber of management, competitive position within target markets, future growth blueprints, and the robustness of cash flow generation. To evaluate its performance, the fund employs a composite benchmark consisting of 30% Numis UK Smaller Companies (excluding investment companies) Index and 70% MSCI All Country World ex UK Small Cap Index. Originally founded on February 15, 1889, under the name F&C Smaller Companies plc, the entity is domiciled in the United Kingdom.

The Tri-Continental Corporation operates as a closed-end equity mutual fund, managed by Columbia Management Investment Advisers, LLC. Its core strategy involves investing in publicly traded large-capitalization companies spanning various sectors within the United States equity markets. The fund's investment performance is benchmarked against the S&P 500 Index. Established in January 1929, it is legally domiciled in the United States.

Worldwide Healthcare Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. The fund is managed by OrbiMed Capital LLC. It invests in public equity markets across the globe. The fund seeks to invest in stocks of companies operating in the healthcare sector, with an emphasis on pharmaceutical and biotechnology companies. It primarily invests in growth stocks of large-cap companies with a market capitalization of at least $5 billion. The fund employs fundamental analysis with a bottom-up stock picking approach to create its portfolio. It benchmarks the performance of its portfolio against the MSCI World Healthcare Index. The fund employs internal research to make its investments. It was formerly known as Finsbury Worldwide Pharmaceutical Trust plc. Worldwide Healthcare Trust PLC was formed in April 1995 and is domiciled in the United Kingdom.

POLAR CAPITAL TECHNOLOGY TRUST PLCAsset ManagementLondon, United Kingdom

65% match

Managed by Polar Capital LLP, Polar Capital Technology Trust plc operates as a closed-end investment company. Its objective is to allocate capital to publicly listed companies across the globe. The trust primarily focuses on enterprises within the technology sector, alongside those in related, technology-dependent fields such as information, media, communications, environmental solutions, computing, healthcare, and renewable energy. Investments are made across the full spectrum of market capitalizations. Its portfolio is constructed through fundamental analysis, with particular emphasis on management quality, the global spread of key technological trends, and identifying international valuation irregularities. The performance of its portfolio is benchmarked against the Dow Jones World Technology Index (Total Return). Initially known as Henderson Technology Trust Plc, the trust was established in the United Kingdom on December 16, 1996.